Thyrocare Technologies Hits 52-Week High on Strong Q2 Earnings
Thyrocare Technologies Ltd. surged to a record high in early trading after reporting a 45% jump in quarterly net profit, fueled by robust diagnostic demand and operational efficiency. The stock peaked at ₹1,474 before paring gains to trade flat at ₹1,258 on the NSE.
Standalone revenue climbed 24% year-over-year to ₹202.23 crore, while EBITDA margins expanded dramatically—consolidated earnings before interest, taxes, depreciation, and amortization ROSE 48%. The board declared an interim dividend of ₹7 per share alongside a 2:1 bonus issue, signaling confidence in sustained growth.
'This performance reflects our fundamental strengths and disciplined execution,' said Group CFO Alok Kumar Jagnani, noting the milestone of the company's 25th anniversary. The diagnostics firm has capitalized on India's expanding healthcare infrastructure, with PAT soaring 82% annually.